Gene · 53353
Papers2,235
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,235
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic and Transcriptomic Analyses of Malignant Pleural Mesothelioma (MPM) Samples Reveal Crucial Insights for Preclinical Testing. | Cancers (Basel) | 2023 | 37345150 | PubTator, text mining | PubMed |
| Genome-Wide Association Study of Breast Density among Women of African Ancestry. | Cancers (Basel) | 2023 | 37345113 | PubTator, text mining | PubMed |
| CNETML: maximum likelihood inference of phylogeny from copy number profiles of multiple samples. | Genome Biol | 2023 | 37340508 | PubTator, text mining | PubMed |
| Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma. | Sci Rep | 2023 | 37340028 | PubTator, text mining | PubMed |
| Neuronal ApoE4 in Alzheimer's disease and potential therapeutic targets. | Front Aging Neurosci | 2023 | 37333457 | PubTator, text mining | PubMed |
| Potential Alternative Therapeutic Modalities for Management Head and Neck Squamous Cell Carcinoma: A Review. | Cancer Control | 2023 | 37328298 | PubTator, text mining | PubMed |
| Mutational landscape of SWI/SNF complex genes reveal correlation to predictive biomarkers for immunotherapy sensitivity in lung adenocarcinoma patients. | ESMO Open | 2023 | 37327699 | PubTator, text mining | PubMed |
| Identification of PANoptosis-relevant subgroups to evaluate the prognosis and immune landscape of patients with liver hepatocellular carcinoma. | Front Cell Dev Biol | 2023 | 37325556 | PubTator, text mining | PubMed |
| The potential role and mechanism of circRNA/miRNA axis in cholesterol synthesis. | Int J Biol Sci | 2023 | 37324939 | PubTator, text mining | PubMed |
| Characterization and clinical verification of immune-related genes in hepatocellular carcinoma to aid prognosis evaluation and immunotherapy. | BMC Cancer | 2023 | 37322434 | PubTator, text mining | PubMed |
| Extensive genetic admixture between Tai-Kadai-speaking people and their neighbours in the northeastern region of the Yungui Plateau inferred from genome-wide variations. | BMC Genomics | 2023 | 37308851 | PubTator, text mining | PubMed |
| Molecular profiling and prognostic biomarkers in chinese non-small cell lung cancer cohort. | Diagn Pathol | 2023 | 37301854 | PubTator, text mining | PubMed |
| Metaplastic Breast Carcinoma in U.S. Population: Racial Disparities, Survival Benefit of Adjuvant Chemoradiation and Future Personalized Treatment with Genomic Landscape. | Cancers (Basel) | 2023 | 37296916 | PubTator, text mining | PubMed |
| Association of Smoking and Respiratory Disease History with Pancreatic Pathologies Requiring Surgical Resection. | Cancers (Basel) | 2023 | 37296897 | PubTator, text mining | PubMed |
| A Multi-Omics Overview of Colorectal Cancer to Address Mechanisms of Disease, Metastasis, Patient Disparities and Outcomes. | Cancers (Basel) | 2023 | 37296894 | PubTator, text mining | PubMed |
| New Actions on Actionable Mutations in Lung Cancers. | Cancers (Basel) | 2023 | 37296880 | PubTator, text mining | PubMed |
| Identification of Basement Membrane-Related Signatures in Gastric Cancer. | Diagnostics (Basel) | 2023 | 37296697 | PubTator, text mining | PubMed |
| ATHENA: an independently validated autophagy-related epigenetic prognostic prediction model of head and neck squamous cell carcinoma. | Clin Epigenetics | 2023 | 37296474 | PubTator, text mining | PubMed |
| The analysis of cathepsin L that mediates cellular SARS-CoV-2 infection leading to COVID-19 in head and neck squamous cell carcinoma. | Front Immunol | 2023 | 37292206 | PubTator, text mining | PubMed |
| Autophagy-related tumor subtypes associated with significant gene expression profiles and immune cell infiltration signatures to reveal the prognosis of non-small cell lung cancer. | J Cancer | 2023 | 37283800 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53353/papers?page=19